Treatment and Prevention of Catheter Related Urinary Tract Infection Use D-mannose
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
New Taipei City、台湾、231
- Taipei Tzu Chi Hospital, Taiwan, R.O.C.
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Patients visit the Urology clinic in Tzu Chi hospital due to long-term catheterization monthly and diagnosed as recurrent UTI last year.
Exclusion Criteria:
- The above patients who unwilling to join this study, patients under 18 years old, women with pregnancy or breastfeeding plans, urological interventions in the past 3 months.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:D-mannose followed by Standard Care
Participants receive D-mannose (one tablet, twice daily) for the first year.
After one year, D-mannose is suspended, and participants receive standard catheter care for the second year.
Follow-up and urine specimen collection occur monthly during scheduled outpatient catheter replacements.
|
Give patients D-mannose, twice a day, one tablet each time, for one year; the research area is divided into two groups, The first group took D-mannose for one year. After the one-year period expired, the use of D-mannose was suspended, and the original standard treatment was resumed treatment, and continued follow-up in the outpatient clinic for one year; the second group maintained the standard treatment for one year, and began to take it after the one-year period expired. Use D-mannose for one year; the grouping method is based on the order of admission of patients in each hospital, with odd-numbered cases in the first group and even-numbered cases in the first group and Second groups. Such patients are fixed in the outpatient clinic to change the urinary catheter every month, so the follow-up time is also arranged during the return visit. Urine specimens were collected at the same time as catheter replacement. |
|
アクティブコンパレータ:Standard Care followed by D-mannose
Participants receive standard catheter care for the first year.
After one year, participants receive D-mannose (one tablet, twice daily) for the second year.
Follow-up and urine specimen collection occur monthly during scheduled outpatient catheter replacements.
|
Give patients D-mannose, twice a day, one tablet each time, for one year; the research area is divided into two groups, The first group took D-mannose for one year. After the one-year period expired, the use of D-mannose was suspended, and the original standard treatment was resumed treatment, and continued follow-up in the outpatient clinic for one year; the second group maintained the standard treatment for one year, and began to take it after the one-year period expired. Use D-mannose for one year; the grouping method is based on the order of admission of patients in each hospital, with odd-numbered cases in the first group and even-numbered cases in the first group and Second groups. Such patients are fixed in the outpatient clinic to change the urinary catheter every month, so the follow-up time is also arranged during the return visit. Urine specimens were collected at the same time as catheter replacement. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Number of symptomatic UTIs requiring treatment
時間枠:Up to 2 years
|
The total number of symptomatic urinary tract infections (UTIs) that required medical treatment during the study period.
|
Up to 2 years
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of asymptomatic positive bacterial culture
時間枠:Up to 2 years
|
The number of participants who developed an asymptomatic positive bacterial culture in their urine samples during the study period.
|
Up to 2 years
|
|
Frequency of urinary catheter obstruction
時間枠:Up to 2 years
|
The total number of urinary catheter obstruction events recorded per participant.
|
Up to 2 years
|
|
Patient and caregiver subjective feelings score
時間枠:Up to 2 years
|
Subjective feelings and satisfaction assessed by the Global Response Assessment (GRA).
The GRA is a 7-point scale with scores ranging from -3 (markedly worse) to +3 (markedly better).
Higher scores indicate greater symptom improvement and better satisfaction.
|
Up to 2 years
|
協力者と研究者
捜査官
- スタディディレクター:Shu-Yu Wu, bachelor、Taichung Tzu Chi Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 10-XD-162
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。